CLINTON GROUP INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CLINTON GROUP INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$1,279,196,000
+142.9%
14,264
+9.9%
0.20%
+545.2%
Q1 2017$526,599,000
+91802.1%
12,980
-9.0%
0.03%
-6.1%
Q4 2016$573,000
+6.1%
14,258
-4.4%
0.03%
+32.0%
Q3 2016$540,000
+93.5%
14,910
+54.7%
0.02%
+108.3%
Q2 2016$279,0009,6350.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders